medical oncology newsroom
.png?sfvrsn=d94b62b5_1 "Website Photo Squares (24)")
FDA Clears Clinical Trial Uses CAR T-Cells to Fight Colorectal Cancer
Developed at CU Anschutz, the therapy targets two pathways that help tumors grow and evade the immune system. The trial will assess the therapy’s safety and ability to attack cancer in patients.
.png?sfvrsn=91060b5_1 "Website Photo Squares (18)")
Game-Changing Clinical Trials for Advanced Prostate Cancer Underway
Laura Graham, MD, is the site PI for the potentially game changing immunotherapy drug trials of a bispecific T-cell engager that links a protein on a T cell with a protein on the tumor.
.png?sfvrsn=9cb4ddb4_1 "Website Photo Squares (9)")
Dr. Wood Receives Grant to Improve Cancer Prevention and Survivorship
Through a five-year grant, oncologist Marie Wood, MD, aims to promote clinical trials that are focused on preventing cancer and improving outcomes for survivors.
f49ba104-56c4-4196-a5c0-50c48d5352ac.png?sfvrsn=af06c8b4_1 "Website Photo Squares (2)")
Navigating How to Talk to Someone Newly Diagnosed with Cancer
Dr. Concannon offers advice on how to talk about cancer with someone who has been newly diagnosed, and what to avoid.
.png?sfvrsn=946bc5b4_1 "Website Photo Squares (1)")
Cancer Care Frameworks that Respect the Values of Older Patient
Dr. Kessler aims to ensure that care for older patients with advanced cancer aligns with their values and priorities - which may differ from younger patients - with what she calls "goal-concordant care".
Dr. Studts Receives Grant to Improve Lung Cancer Screening Nationwide
Jamie Studts, PhD is co-principal investigator of a recently awarded $1.5 million NCI grant that will support the first step in a multi-phase process to improve lung cancer screening efforts at 60 sites across the United States.
Worldwide Collaboration Sheds Light on Lung Cancer Therapy
Tejas Patil, MD, led a global study of patients on three continents, focused on treatment strategies for non-small cell lung cancer. The study involved patients and researchers from the CU Cancer Center as well as cancer facilities in Canada, China, Italy, and the University of Pennsylvania.
38b223e8302864d9a5bfff0a001ce385.png?sfvrsn=fa9a47b4_1 "Website Photo Squares (4)")
Effective Treatments for HER2-positive Breast Cancer Patients
Elena Shagisultanova, MD, PhD, is working to uncover effective treatments for HER2-positive breast cancer patients by combining different drugs to counteract the cancer cells’ proliferation.